勘误：白血病多药耐药过程中的代谢重编程。
Corrigendum: Metabolic Reprogramming During Multidrug Resistance in Leukemias.
作者信息
Vidal Raphael Silveira, Quarti Julia, Rodrigues Mariana Figueiredo, Rumjanek Franklin D, Rumjanek Vivian M
机构信息
Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Instituto de Nutrição Josué de Castro, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
出版信息
Front Oncol. 2018 Nov 12;8:441. doi: 10.3389/fonc.2018.00441. eCollection 2018.
Abstract
[This corrects the article DOI: 10.3389/fonc.2018.00090.].
摘要
[本文更正了文章DOI：10.3389/fonc.2018.00090。]
相似文献
1
Corrigendum: Metabolic Reprogramming During Multidrug Resistance in Leukemias.勘误：白血病多药耐药过程中的代谢重编程。
Front Oncol. 2018 Nov 12;8:441. doi: 10.3389/fonc.2018.00441. eCollection 2018.
2
Metabolic Reprogramming During Multidrug Resistance in Leukemias.白血病多药耐药过程中的代谢重编程
Front Oncol. 2018 Apr 4;8:90. doi: 10.3389/fonc.2018.00090. eCollection 2018.
3
Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma.勘误：将SMAC模拟物LCL161与吉西他滨加顺铂疗法联合使用可抑制并预防胆管癌中多药耐药性的出现。
Front Oncol. 2023 Jan 6;12:1124912. doi: 10.3389/fonc.2022.1124912. eCollection 2022.
4
Corrigendum: Metabolic Dependencies in Pancreatic Cancer.勘误：胰腺癌中的代谢依赖性
Front Oncol. 2019 Jan 31;8:672. doi: 10.3389/fonc.2018.00672. eCollection 2018.
5
Corrigendum: A Novel Role of Connexin 40-Formed Channels in the Enhanced Efficacy of Photodynamic Therapy.勘误：连接蛋白40形成的通道在增强光动力疗法疗效中的新作用。
Front Oncol. 2022 Feb 23;12:853278. doi: 10.3389/fonc.2022.853278. eCollection 2022.
6
Corrigendum: DDX19A Promotes Metastasis of Cervical Squamous Cell Carcinoma by Inducing NOX1-Mediated ROS Production.勘误：DDX19A通过诱导NOX1介导的活性氧生成促进宫颈鳞状细胞癌转移。
Front Oncol. 2022 Jun 9;12:914765. doi: 10.3389/fonc.2022.914765. eCollection 2022.
7
Corrigendum: Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma.勘误：靶向JUN、CEBPB和HDAC3：克服缺氧性胶质母细胞瘤耐药性的新策略。
Front Oncol. 2020 Apr 28;10:644. doi: 10.3389/fonc.2020.00644. eCollection 2020.
8
Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.勘误：非编码RNA：肝细胞癌中索拉非尼耐药性的新兴调节因子
Front Oncol. 2020 Mar 3;10:277. doi: 10.3389/fonc.2020.00277. eCollection 2020.
9
Corrigendum: Regulatory Role of Hexokinase 2 in Modulating Head and Neck Tumorigenesis.勘误：己糖激酶2在调节头颈部肿瘤发生中的调控作用。
Front Oncol. 2020 Mar 31;10:410. doi: 10.3389/fonc.2020.00410. eCollection 2020.
10
Corrigendum: Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide.勘误：米非司酮作为一种潜在疗法，用于降低与胶质母细胞瘤对替莫唑胺耐药相关的血管生成和P-糖蛋白水平。
Front Oncol. 2021 Mar 22;11:675806. doi: 10.3389/fonc.2021.675806. eCollection 2021.
Zotero 插件